检索

期
标题
作者
卷 26, 编号 1 (2024)
Efficacy and safety of alpelisib in patients with HR+HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study
Sultanbaev A., Kolyadina I., Menshikov K., Musin S., Nasretdinov A., Sultanbaeva N., Rakhimov R., Lipatov D., Menshikova I., Izmailov A., Lipatova E.
PDF
(Rus)
卷 26, 编号 1 (2024)
Detection of mutations in the BRAF in patients with melanoma in routine clinical practice: Survey results
Orlova K., Demidov L.
PDF
(Rus)
卷 23, 编号 1 (2021)
Piqray – basic questions at the start: whom to test? whom to treat? how to treat? Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 29th, 2021
Board E.
PDF
(Rus)
卷 16, 编号 2 (2014)
Press-release. «Merck Serono» announces new retrospective analysis shows significant clinical benefit in overall survival for metastatic colorectal cancer patients with RAS wild-type tumors receiving Erbitux® plus FOLFIRI
卷 22, 编号 4 (2020)
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Mazurina N., Artamonova E., Beloyartseva M., Volkova E., Ganshina I., Troshina E., Tjulandin S., Chubenko V.
PDF
(Rus)
卷 8, 编号 2 (2006)
Nasledstvennyy rak zheludka: molekulyarno-geneticheskie i klinicheskie aspekty
Nikulin M., Lyubchenko L., Sel'chuk V., Stilidi I.
卷 22, 编号 4 (2020)
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
Poddubnaya I., Gligorov J., Zhukova L., Kovalenko E., Frolova M.
PDF
(Rus)
卷 8, 编号 1 (2006)
Molekulyarno-biologicheskie faktory prognoza pri B-kletochnom khronicheskom limfoleykoze
Nikitin E., Malakho S., Biderman B., Poltaraus A., Sudarikov A.
卷 20, 编号 2 (2018)
New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors
Laktionov K., Reutova E., Nelyubina L., Pitkevich M., Okruzhnova M., Ardzinba M., Yudin D., Demidova I., Zaretsky A.
PDF
(Rus)
卷 25, 编号 1 (2023)
The possibilities of therapy of patients with metastatic colorectal cancer with BRAF V600E mutation. Clinical cases
Polyanskaya E., Fedyanin M.
PDF
(Rus)
卷 19, 编号 1 (2017)
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.
PDF
(Rus)
卷 24, 编号 1 (2022)
Management of patients with hormone receptor-positive HER2-negative metastatic breast cancer: data of randomized trials and real-world evidence
Editorial B.
PDF
(Rus)
卷 18, 编号 3 (2016)
Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene
Ryazhenov V., Gorokhova S.
PDF
(Rus)
卷 23, 编号 4 (2021)
The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Shlivko I., Garanina O., Artamonova E., Ganshina I., Zhukova L., Koroleva I., Michenko A., Semiglazova T., Filonenko D.
PDF
(Rus)
卷 18, 编号 2 (2016)
Supportive therapy for ovarian cancer
Pokataev I., Tyulyandin S.
PDF
(Rus)
卷 23, 编号 2 (2021)
PIK3CA mutation: changing the paradigm of HR+ HER2-negative metastatic breast cancer therapy. Review of the Novartis Pharma satellite symposium, held as part of a virtual forum dedicated to the diagnosis and treatment of patients with hormone-dependent HER2-negative advanced breast cancer with a PIK3CA gene mutation. April 23, 2021
Board E.
PDF
(Rus)
卷 16, 编号 3 (2014)
Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib
Smolin A., Gorbacheva A.
1 - 17 的 17 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##